Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jian‐Yong Zou"'
Autor:
Jia Yang, Hai-Cheng Liu, Jian-Qing Zhang, Jian-Yong Zou, Xin Zhang, Wo-Ming Chen, Yong Gu, Hai Hong
Publikováno v:
Immunity & Ageing, Vol 20, Iss 1, Pp 1-15 (2023)
Abstract Background Immunosenescence occurs as people age, leading to an increased incidence of age-related diseases. The number of senescent T cells also rises with age. T cell senescence and immune response dysfunction can result in a decline in im
Externí odkaz:
https://doaj.org/article/dbb475e4ddd44bd3af8b7cd46bec4c67
Autor:
Hao‐Shuai Yang, He‐Yuan Cai, Shi‐Chao Shan, Ting‐Fei Chen, Jian‐Yong Zou, Maimaiti Abudurufu, Hong‐He Luo, Yi‐Yan Lei, Zun‐Fu Ke, Ying Zhu
Publikováno v:
Molecular Oncology, Vol 17, Iss 2, Pp 365-377 (2023)
The improvement of treatment for patients with ‘driver‐gene‐negative’ lung adenocarcinoma (LUAD) remains a critical problem to be solved. We aimed to explore the role of methylation of N6 adenosine (m6A)‐related long noncoding RNA (lncRNA)
Externí odkaz:
https://doaj.org/article/e6889ac32332414a93f83ba9ee9e3436
Publikováno v:
Cancer Medicine, Vol 11, Iss 11, Pp 2259-2270 (2022)
Abstract Objective Examining the role of immune‐related genes (IRGs) in “driver gene negative” lung adenocarcinoma (LUAD) may provide new ideas for the treatment and study for this LUAD subgroup. We aimed to find the hub immune‐related gene p
Externí odkaz:
https://doaj.org/article/12dea516daa841d3b76790dc8417b12e
Autor:
Hao‐Shuai Yang, He‐Yuan Cai, Shi‐Chao Shan, Ting‐Fei Chen, Jian‐Yong Zou, Maimaiti Abudurufu, Hong‐He Luo, Yi‐Yan Lei, Zun‐Fu Ke, Ying Zhu
Publikováno v:
Molecular Oncology. 17:365-377
The improvement of treatment for patients with 'driver-gene-negative' lung adenocarcinoma (LUAD) remains a critical problem to be solved. We aimed to explore the role of methylation of N6 adenosine (m6A)-related long noncoding RNA (lncRNA) in stratif
Autor:
null Hao‐Shuai Yang, null He‐Yuan Cai, null Shi‐Chao Shan, null Ting‐Fei Chen, null Jian‐Yong Zou, null Maimaiti Abudurufu, null Hong‐He Luo, null Yi‐Yan Lei, null Zun‐Fu Ke, null Ying Zhu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ba1f86d157c5386859fe05ab3505aad
https://doi.org/10.1002/1878-0261.13323/v2/response1
https://doi.org/10.1002/1878-0261.13323/v2/response1
Autor:
Hao-Shuai Yang, He-Yuan Cai, Shi-Chao Shan, Ting-Fei Chen, Jian-Yong Zou, Hong-He Luo, Yi-Yan Lei, Zun-Fu Ke, Ying Zhu
Publikováno v:
SSRN Electronic Journal.
Autor:
Ying Ying Tang, Chuan Gang Lu, Hai Hong, Yu Qing Zhang, Si Yuan Sheng, Yi Yan Lei, Yong Gu, Jian Yong Zou
Publikováno v:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
The canonical Wnt-β-catenin signaling pathway arrests the differentiation of T cells and plays an important role in phenotypic maintenance of naive T cells and stem cell-like memory T cells in human peripheral blood, but its effect on tumor-infiltra
Autor:
Jian Yong Zou, Hai Hong, Si Yuan Sheng, Chuan Gang Lu, Yong Gu, Yan Feng Wang, Ying Ying Tang
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 42(8)
On the basis of the autologous tumor-infiltrating lymphocytes (TILs) or genetically modified TILs for adoptive cell therapy have received more attention. Programmed cell death protein 1 (PD-1) expression on the T cells exert complex response during t
Autor:
Chuan Gang Lu, Rongfu Wang, Jian Yong Zou, Yong Gu, Hai Hong, Si Yuan Sheng, Ying Ying Tang, Yu Qing Zhang
Publikováno v:
Journal of Immunotherapy. 40:1-10
Adoptive cell therapy using autologous tumor-infiltrating lymphocytes (TILs) or genetically modified lymphocytes from TILs is a new effective approach, but the application of TIL immunotherapy is still limited in many solid tumors. Knowledge of the c
Publikováno v:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
Supplemental Digital Content is available in the text.
Human stem cell–like memory T (Tscm) cells are long-lived, self-renewing memory lymphocytes that can differentiate into effector cells and mediate strong antitumour response in murine mode
Human stem cell–like memory T (Tscm) cells are long-lived, self-renewing memory lymphocytes that can differentiate into effector cells and mediate strong antitumour response in murine mode